- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 283429, 10 pages
Organic Anion Transporter 5 Renal Expression and Urinary Excretion in Rats with Vascular Calcification
Area Farmacología, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 531, 2000 Rosario, Argentina
Received 15 April 2013; Revised 25 July 2013; Accepted 29 August 2013
Academic Editor: Marlies Ostermann
Copyright © 2013 María Herminia Hazelhoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. C. Christian and L. A. Fitzpatrick, “Vascular calcification,” Current Opinion in Nephrology and Hypertension, vol. 8, no. 4, pp. 443–448, 1999.
- J. Atkinson, “Vascular calcium overload: physiological and pharmacological consequences,” Drugs, vol. 44, no. 1, pp. 111–118, 1992.
- M. Abedin, Y. Tintut, and L. L. Demer, “Vascular calcification: mechanisms and clinical ramifications,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 7, pp. 1161–1170, 2004.
- A. Brandoni and A. M. Torres, “Experimental arteriosclerosis,” in Experimental Surgical Models in the Laboratory Rat, A. Rigalli and V. Di Loreto, Eds., pp. 205–207, CRC Press Taylor and Francis Group, Boca Raton, Fla, USA, 2009.
- N. B. Quaglia, C. G. Hofer, and A. M. Torres, “Pharmacokinetics of organic anions in rats with arterial calcinosis,” Clinical and Experimental Pharmacology and Physiology, vol. 29, no. 1-2, pp. 48–52, 2002.
- N. B. Quaglia, A. Brandoni, A. Ferri, and A. M. Torres, “Early manifestation of nephropathy in rats with arterial calcinosis,” Renal Failure, vol. 25, no. 3, pp. 355–366, 2003.
- N. B. Quaglia, A. Brandoni, S. R. Villar, and A. M. Torres, “Haemodynamic and tubular renal dysfunction in rats with sustained arterial calcinosis,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 4, pp. 231–236, 2004.
- R. Bulacio, M. H. Hazelhoff, and A. M. Torres, “Renal expression and function of oat1 and oat3 in rats with vascular calcification,” Pharmacology, vol. 90, no. 1-2, pp. 66–77, 2012.
- G. L. Youngblood and D. H. Sweet, “Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney,” American Journal of Physiology, vol. 287, no. 2, pp. F236–F244, 2004.
- N. Anzai, P. Jutabha, A. Enomoto et al., “Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules,” Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 2, pp. 534–544, 2005.
- N. Anzai, Y. Kanai, and H. Endou, “Organic anion transporter family: current knowledge,” Journal of Pharmacological Sciences, vol. 100, no. 5, pp. 411–426, 2006.
- J. O. Kwak, H. W. Kim, K. J. Oh, C. B. Ko, H. Park, and S. H. Cha, “Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 4, pp. 369–375, 2005.
- G. Di Giusto, N. Anzai, H. Endou, and A. M. Torres, “Oat5 and NaDC1 protein abundance in kidney and urine after renal ischemic reperfusion injury,” Journal of Histochemistry and Cytochemistry, vol. 57, no. 1, pp. 17–27, 2009.
- G. Di Giusto and A. M. Torres, “Organic anion transporter 5 renal expression and urinary excretion in rats exposed to mercuric chloride: a potential biomarker of mercury-induced nephropathy,” Archives of Toxicology, vol. 84, no. 10, pp. 741–749, 2010.
- R. P. Bulacio and A. M. Torres, “Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity,” Archives of Toxicology, 2013.
- D. H. Han, S. G. Piao, J. Song et al., “Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene,” Transplantation, vol. 90, no. 2, pp. 135–141, 2010.
- J. J. Sedmak and S. E. Grossberg, “A rapid, sensitive, and versatile assay for protein using coomassie brilliant blue G250,” Analytical Biochemistry, vol. 79, no. 1-2, pp. 544–552, 1977.
- M. H. Hazelhoff, R. P. Bulacio, and A. M. Torres, “Gender related differences in kidney injury induced by mercury,” International Journal of Molecular Sciences, vol. 13, no. 8, pp. 10523–10536, 2012.
- T. Pisitkun, R. Johnstone, and M. A. Knepper, “Discovery of urinary biomarkers,” Molecular and Cellular Proteomics, vol. 5, no. 10, pp. 1760–1771, 2006.
- C. P. Price, R. G. Newall, and J. C. Boyd, “Use of protein: creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review,” Clinical Chemistry, vol. 51, no. 9, pp. 1577–1586, 2005.
- G. Xin, M. Wang, L.-L. Jiao, G.-B. Xu, and H.-Y. Wang, “Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria,” Clinica Chimica Acta, vol. 350, no. 1-2, pp. 35–39, 2004.
- F. Umenishi, S. N. Summer, M. Cadnapaphornchai, and R. W. Schrier, “Comparison of three methods to quantify urinary aquaporin-2 protein,” Kidney International, vol. 62, no. 6, pp. 2288–2293, 2002.
- R. Heiene, L. Moe, and G. Mølmen, “Calculation of urinary enzyme excretion, with renal structure and function in dogs with pyometra,” Research in Veterinary Science, vol. 70, no. 2, pp. 129–137, 2001.
- F. G. Brivet, D. J. Kleinknecht, P. Loirat, and P. J. M. Landais, “Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study,” Critical Care Medicine, vol. 24, no. 2, pp. 192–198, 1996.
- E. M. Levy, C. M. Viscoli, and R. I. Horwitz, “The effect of acute renal failure on mortality: a cohort analysis,” Journal of the American Medical Association, vol. 275, no. 19, pp. 1489–1494, 1996.
- J. V. Bonventre, “Diagnosis of acute kidney injury: from classic parameters to new biomarkers,” Contributions to Nephrology, vol. 156, pp. 213–219, 2007.
- B. C. Vidal, J. V. Bonventre, and S. I-Hong Hsu, “Towards the application of proteomics in renal disease diagnosis,” Clinical Science, vol. 109, no. 5, pp. 421–430, 2005.
- V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, “Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury,” American Journal of Physiology, vol. 290, no. 2, pp. F517–F529, 2006.
- J. Mishra, M. A. Qing, A. Prada et al., “Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534–2543, 2003.
- Y. Muramatsu, M. Tsujie, Y. Kohda et al., “Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury,” Kidney International, vol. 62, no. 5, pp. 1601–1610, 2002.
- P. Ivarsen, J. Frøkiær, N. K. Aagaard et al., “Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis,” Gut, vol. 52, no. 8, pp. 1194–1199, 2003.
- H. Wen, J. Frøkiær, T.-H. Kwon, and S. Nielsen, “Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin- dependent apical pathway,” Journal of the American Society of Nephrology, vol. 10, no. 7, pp. 1416–1429, 1999.
- D. du Cheyron, C. Daubin, J. Poggioli et al., “Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF,” American Journal of Kidney Diseases, vol. 42, no. 3, pp. 497–506, 2003.
- W. Sun, R. R. Wu, P. D. Van Poelje, and M. D. Erion, “Isolation of a family of organic anion transporters from human liver and kidney,” Biochemical and Biophysical Research Communications, vol. 283, no. 2, pp. 417–422, 2001.
- S. A. Eraly and S. K. Nigam, “Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters,” Biochemical and Biophysical Research Communications, vol. 297, no. 5, pp. 1159–1166, 2002.
- C. Srimaroeng, J. L. Perry, and J. B. Pritchard, “Physiology, structure, and regulation of the cloned organic anion transporters,” Xenobiotica, vol. 38, no. 7-8, pp. 889–935, 2008.
- A. L. VanWert, M. R. Gionfriddo, and D. H. Sweet, “Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology,” Biopharmaceutics and Drug Disposition, vol. 31, no. 1, pp. 1–71, 2010.
- D. Breljak, M. Ljubojevic, D. Balen et al., “Renal expression of organic anion transporter Oat5 in rats and mice exhibits the female-dominant sex differences,” Histology and Histopathology, vol. 25, no. 11, pp. 1385–1402, 2010.
- C. G. Duarte, L. R. Elveback, and R. R. Liedtje, “Creatinina,” in Pruebas de la Función Renal. Procedimientos Y Diagnóstico Clínicos Por el Laboratorio, C. G. Duarte, Ed., pp. 1–26, Salvat Eds SA, Barcelona, Spain, 1983.
- W. G. Guder and B. D. Ross, “Enzyme distribution along the nephron,” Kidney International, vol. 26, no. 2, pp. 101–111, 1984.
- J. Westhuyzen, Z. H. Endre, G. Reece, D. M. Reith, D. Saltissi, and T. J. Morgan, “Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit,” Nephrology Dialysis Transplantation, vol. 18, no. 3, pp. 543–551, 2003.
- G. Traina, “Intracellular free calcium and its modulation,” Archives Italiennes de Biologie, vol. 134, no. 4, pp. 323–339, 1996.
- H. L. Henry and A. W. Norman, “Vitamin D: metabolism and biological actions,” Annual Review of Nutrition, vol. 4, pp. 493–520, 1984.
- M. A. Ferguson, V. S. Vaidya, and J. V. Bonventre, “Biomarkers of nephrotoxic acute kidney injury,” Toxicology, vol. 245, no. 3, pp. 182–193, 2008.